C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2006
11/21/2006	US7138513 Genes encoding for genetic stability, gene expression and folding proteins
11/21/2006	US7138509 GANP protein
11/21/2006	US7138508 Inhibitor protein of the wnt signal pathway
11/21/2006	US7138501 Antibodies that immunospecifically bind BLyS
11/21/2006	US7138500 Antibodies to human 4-1BB
11/21/2006	US7138498 DNA (RNA) encoding such chemokine polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such chemokine polypeptides for the treatment of
11/21/2006	US7138497 Genetic engineering; crosslinking polypeptide on carrier
11/21/2006	US7138496 Antibody that binds to loop 6 of human CXCR4, especially a single chain antibody
11/21/2006	US7138494 Comprises amino acid transport protein (ASC-1) for regulating NMDA-type glutamic acid receptor; treatment of nervous system disorders; antiproliferative agents; gene expression inhibition
11/21/2006	US7138371 Remodeling and glycoconjugation of peptides
11/21/2006	US7138262 High mannose proteins and methods of making high mannose proteins
11/21/2006	US7138258 polypeptide that has alpha -2,3-sialyltransferase activity; involved in synthesis of lipooligosaccharides including gangliosides and ganglioside mimics; campylobacter jejuni (C. jejuni)
11/21/2006	US7138255 Method of isolation and self-assembly of small protein particles from blood and other biological materials
11/21/2006	US7138253 Nucleic acid encoding a peptide that binds streptavidin with a dissociation constant less than 10 mu M and that is not disulfide bonded or cyclized; may be expressed as part of fusion proteins to facilitate the detection, quantitation, and purification of proteins of interest.
11/21/2006	US7138234 Gene involved in CADASIL, method of diagnosis and therapeutic application
11/21/2006	US7138233 IN vitro sorting method
11/21/2006	US7138228 Protein O-sulfonation
11/21/2006	US7138117 Antigen-binding fragment or antibody which binds to a mammalian CC-chemokine receptor 4 (CCR4); medical diagosis, therapy, or prophylaxis; antiinflammatory agents
11/21/2006	US7138116 Antithrombotic agent and humanized anti-von Willebrand factor monoclonal antibody
11/21/2006	US7138115 Administering monoclonal or polyclonal antibody to treat multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease
11/21/2006	CA2478621C Botulinum toxin pharmaceutical compositions
11/21/2006	CA2433386C Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r9
11/21/2006	CA2341143C Production of motif-specific and context-independent antibodies using peptide libraries as antigens
11/21/2006	CA2201153C Monoclonal antibody to human cardiac myoglobin
11/21/2006	CA1341515C Hormone receptor compositions and methods
11/17/2006	CA2549902A1 Cd44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
11/16/2006	WO2006121810A2 Trimeric ox40-immunoglobulin fusion protein and methods of use
11/16/2006	WO2006121168A1 Human monoclonal antibodies to programmed death 1(pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
11/16/2006	WO2006121165A1 Method for producing protein
11/16/2006	WO2006121159A1 Humanized cdr-grafted antibody specifically reacting with cd10 and antibody fragment of the same
11/16/2006	WO2006121047A1 Method for determination of megsin in biological sample
11/16/2006	WO2006120678A2 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
11/16/2006	WO2006104677A3 Antibodies that bind ov064 and methods of use therefor
11/16/2006	WO2001057190A3 Novel nucleic acids and polypeptides
11/16/2006	US20060259996 Structure-based methods and compositions useful in designing, identifying, and producing molecules which act as functional modulators of TDF-like (tissue differentiation factor) receptors; methods of detecting, preventing, and treating TDF-associated disorders
11/16/2006	US20060259995 Proteases, nucleic acids encoding them and methods for making and using them
11/16/2006	US20060259993 Amidases, nucleic acids encoding them and methods for making and using them
11/16/2006	US20060259988 Use of dg931 protein for treating diabetes, obesity and metabolic syndrome
11/16/2006	US20060259987 Variants of antithrombin III
11/16/2006	US20060258850 Method for preparing human serum albumin through heat-treatment in the presence of divalent cation
11/16/2006	US20060258840 Peroxisome proliferator-activated receptor
11/16/2006	US20060258611 Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference
11/16/2006	US20060258596 Antimicrobial agents
11/16/2006	US20060258594 Antibodies to the HIV-1 Tat protein, which bind specifically to a specific epitope found in different HIV-1 strains and subtypes; for use in passive therapy
11/16/2006	US20060258593 Methods and compositions for the treatment of gastrointestinal disorders
11/16/2006	US20060258585 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
11/16/2006	US20060258576 Gdnf-related neuropeptides
11/16/2006	US20060258574 Novel compositions and methods for the treatment of psoriasis
11/16/2006	US20060258563 Nitrogen Oxide scavenging ability; digesting cytochrome c with restriction enzyme; use in prophylactic and therapeutics, measuring/treating nitrogen oxide concentrations in air, exhaust gas or water
11/16/2006	US20060258554 Bgl6 beta-glucosidase and nucleic acids encoding the same
11/16/2006	US20060257997 High throughput synthesis system and synthesizer for automatically performing the system
11/16/2006	US20060257990 Carbonic anhydrase having increased stability under high temperature conditions
11/16/2006	US20060257989 Truncated aggrecanase molecules
11/16/2006	US20060257975 Encoded by nucleic acid of given sequence; hybridizes to complement of nucleic acid; use as molecular weight markers,
11/16/2006	US20060257974 Vaccinia virus vector comprising a nucleic acid encoding a fusion protein amino acid sequence consisting of Vif, Vpr, Vpu, Vpx, Rev, Tat, and Nef; genetic vaccines for treating viral diseases
11/16/2006	US20060257973 Pseudomycin production by pseudomonas syringae
11/16/2006	US20060257972 Purification of human monoclonal antibody and human polyclonal antibody
11/16/2006	US20060257971 Antibodies to pro1561 polypeptide
11/16/2006	US20060257970 Human HAC3
11/16/2006	US20060257965 Extracellular matrix signalling molecules
11/16/2006	US20060257959 Glucose dehydrogenase
11/16/2006	US20060257947 Thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibdies and other binding agents
11/16/2006	US20060257928 ANGE gene in atopy
11/16/2006	US20060257927 Processes for purification of recombinant proteins
11/16/2006	US20060257921 Novel nucleic acid molecules and polypeptides encoding baboon TAFI
11/16/2006	US20060257918 Polynucleotide encoding a novel human G-protein coupled receptor variant of the relaxin receptor HGPRBMY5v1, and variants thereof
11/16/2006	US20060257913 Genetic polymorphisms associated with myocardial infarction and uses thereof
11/16/2006	US20060257912 Methods and sequences to suppress primate huntington gene expression
11/16/2006	US20060257911 Of given nucleotide sequence; diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders
11/16/2006	US20060257904 Agglomeration protein cascades, compositions and methods regarding the same
11/16/2006	US20060257897 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/16/2006	US20060257882 Novel polynuceotides and polypeptides encoded thereby
11/16/2006	US20060257872 Cell lines and host nucleic acid sequences related to infectious disease
11/16/2006	US20060257868 Tissue specific genes and gene clusters
11/16/2006	US20060257856 Heterodimeric receptor libraries using phagemids
11/16/2006	US20060257500 TRPC6 involved in glomerulonephritis
11/16/2006	US20060257479 Long-acting molecules in sustained release formulations
11/16/2006	US20060257421 Pneumolysin derivatives
11/16/2006	US20060257418 Vaccine
11/16/2006	US20060257404 Modulators of the P2Y10 receptor useful in altering T lymphocyte function
11/16/2006	US20060257399 Mixture comprising n-glycan modified antibodies exhibiting increased antibody-dependent cellular cytoxicity (ADCC); targeted destruction of tumor cells
11/16/2006	US20060257393 Method for protecting thiol group of protein
11/16/2006	US20060257387 Sugar chain synthase gene
11/16/2006	CA2607595A1 Recombinant n-glycosylated proteins from procaryotic cells
11/16/2006	CA2607281A1 Anti-cd19 antibody therapy for autoimmune disease
11/16/2006	CA2607147A1 Human monoclonal antibodies to programmed death 1(pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
11/16/2006	CA2606809A1 Trimeric ox40-immunoglobulin fusion protein and methods of use
11/16/2006	CA2586250A1 Compositions for treating respiratory viral infections and their use
11/15/2006	EP1721986A1 Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins
11/15/2006	EP1721979A1 Compositions and methods for increasing bone mineralisation
11/15/2006	EP1721978A1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof
11/15/2006	EP1721972A2 Telomere protein trf2 dna-binding domain mutant protein, telomere dna mutant and utilization of complex structure of trf2 dna-binding domain with double-stranded dna
11/15/2006	EP1721969A2 Mutant bioluminescent protein, and process for producing the mutant bioluminescent protein
11/15/2006	EP1720997A1 Methods to make and use antibodies of improved cross-reactivity
11/15/2006	EP1720996A1 Fusion proteins containing recombinant cytotoxic rnases
11/15/2006	EP1720902A1 Mutein of a bone morphogenetic protein and use thereof
11/15/2006	EP1720898A2 Antihypertensive peptides from casein hydrolysates
11/15/2006	EP1720405A2 Manufacture of highly phosphorylated lysosomal enzymes and uses thereof
11/15/2006	EP1687328A4 Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction
11/15/2006	EP1283869B1 Novel bee venom polypeptides and methods of use thereof

1 ... 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 ... 1125